SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-19-000017
Filing Date
2019-04-05
Accepted
2019-04-05 17:19:36
Documents
6
Period of Report
2019-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20190405form8xk.htm 8-K 32606
2 EXHIBIT 99.1 xlrn-20190405form8kxex991.htm EX-99.1 11056
3 EXHIBIT 99.2 xlrn-20190405form8kxex992.htm EX-99.2 23696
4 image1a02.gif GRAPHIC 8811
5 image2.gif GRAPHIC 11525
6 image2a02.gif GRAPHIC 8396
  Complete submission text file 0001280600-19-000017.txt   108508
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 19735922
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences